Data_Sheet_1_Evaluation of Sialyl-Lactotetra as a Marker for Epithelial Ovarian Tumors.PDF (2.09 MB)

Data_Sheet_1_Evaluation of Sialyl-Lactotetra as a Marker for Epithelial Ovarian Tumors.PDF

Download (2.09 MB)
dataset
posted on 23.09.2020 by Angela Barone, Anna Linder, Constantina Mateoiu, Rasmus Köster Larsen, Ola Blixt, Susann Teneberg, Karin Sundfeldt

Ovarian carcinoma is a heterogeneous disease with distinct molecular and histological profiles, ranging from low grade atypia to highly aggressive tumors associated with a poor prognosis. In the present study, glycosphingolipids were isolated from human high-grade serous ovarian carcinoma, whereby the novel stem cell marker Sialyl-lactotetra (S-Lc4) was characterized in two out of three cases. The presence and level of S-Lc4 was further evaluated immunohistochemically in a cohort of patients with ovarian tumors ranging from benign lesions to high grade serous carcinoma (n = 478). Its expression was assessed in association with tumor grade, stage, histology, and survival. The data showed that S-Lc4 is most common and highly expressed in borderline type tumors and carcinomas with low levels of aggressiveness, such as mucinous, endometrioid, and low grade serous. Accordingly, S-Lc4-positivity was associated with better disease-free survival. The expression of S-Lc4 was seemingly associated with lineage continuity and could be traced from premalignant lesions to carcinoma, suggesting inheritance by a stem cell lineage that gives rise to generally indolent tumors.

History

References

Licence

Exports